The Nikolas Symposia and histiocytosis

Nature Reviews Cancer

Volumn 5, Issue 6, 2005, Pages 488-494

  Beverley, Peter C L ^a   Egeler, R Maarten ^b   Arceci, Robert J ^c   Pritchard, Jon ^d  

^a NIHR Biomedical Researcg Centre   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRITIC CELL; HEMATOPOIETIC STEM CELL; HISTIOCYTE; HISTIOCYTOSIS; HUMAN; LANGERHANS CELL; MACROPHAGE; MEDICAL LITERATURE; PRIORITY JOURNAL; REVIEW;

CELL DIFFERENTIATION; CHILD; DENDRITIC CELLS; DIAGNOSIS, DIFFERENTIAL; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; MACROPHAGES; MONOCYTES; PROGNOSIS;

EID: 20344363660     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1632     Document Type: Review

References (50)

1. Carstensen, H. & Ornvold, K. The epidemiology of Langertians cell histiocytosis in children in Denmark, 1975-1989. Med. Pediatr. Oncol. 21, 387-388 (1993).
2. Stepp, S. E. et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286, 1957-1959 (1999).
3. Ohadi, M. et al. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am. J. Hum. Genet. 64, 165-171 (1999).
4. Titgemeyer, C. et al. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study. Med. Pediatr. Oncol. 37, 108-114 (2001).
5. Minkov, M. et al. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group. Klin. Padiatr. 212, 139-144 (2000).
6. Haupt, R. et al. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group. Pediatr. Blood. Cancer. 42, 438-444 (2004).
7. Grois, N., Tsunematsu, Y., Barkovich, J. & Favara, B. E. Central nervous system in Langerhans cell Histiocytosis. Br. J. Cancer 70, S24-S28 (1994).
8. Nanduri, V. R. et al. Cognitive outcome of long-term survivors of multi-system Langerhans cell Histiocytosis: a single institution cross-sectional study. J. Clin. Oncol. 21, 2961-2967 (2003).
9. Egeler, R. M. et al. The relation of Langerhans cell Histiocytosis to acute leukaemia, lymphoma and other solid tumours. Hematol. Oncol. Clin. North Am. 12, 369-378 (1998).
10. Magni, M. et al. Identical rearrangement of immunoglobulin heavy chain gene in neoplastic Langerhans cells and B-lymphocytes: evidence for a common precursor. Leuk. Res. 26, 1131-1133 (2002).
11. Arico, M. et al. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur. J. Cancer. 39, 2341-2348 (2003).
12. Malpas, J. S. & Norton, A. J. Langerhans cell histiocytosis in the adult. Med. Pediatr. Oncol. 27, 540-546 (1996).
13. Pritchard, J., Gordon, I., Beverley, P. C. L. & Chu, A. C. CD1 antibody immunolocalisation in Langerhans' cell histiocytosis. Lancet 342, 367-368 (1993).
14. Kelly, K. M. et al. Successful in vivo immunolocalisation of Langerhans cell histiocytosis with use of a monoclonal antibody, NA1/34. J. Pediatr. 125, 717-722 (1994).
15. Writing Group of the Histiocyte Society et al. Histiocytosis syndromes in children. Lancet 2, 41-42 (1987).
16. Favara, B. Contemporary classification of histiocytic disorders. The WHO Committee on Histiocytic/ Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte. Med. Paediatr. Oncol. 29, 157-166 (1997).
17. McClain, K. & Weiss, R. A. Viruses and Langerhans cell histiocytosis: is there a link? Br. J. Cancer 23, S34-S36 (1994).
18. McClain, K., Jin, H., Gresik, V. & Favara, B. Langerhans cell histiocytosis: lack of a viral etiology. Am. J. Hematol. 47, 16-20 (1994).
19. Isaacson, P. G. & Du, M. Q. MALT lymphoma: from morphology to molecules. Nature Rev. Cancer. 4, 644-653 (2004).
20. Dewhurst, S. Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system. Herpes 11, 105A-111A (2004).
21. Pantanowitz, L. & Dezube, B. J. Advances in the pathobiology and treatment of Kaposi sarcoma. Curr. Opin. Oncol. 16, 443-449 (2004).
22. + T cells vary in differentiation phenotype in different persistent virus infections. Nature Med. 6, 379-385 (2002).
23. + T lymphocytes depend on infection with CMV. J. Immunol. 170, 4342-4348 (2003).
24. Nezelof, C. & Basset, F. An hypothesis Langerhans cell histiocytosis: the failure of the immune system to switch from an innate to an adaptive mode. Pediatr. Blood Cancer 42, 398-400 (2004).
25. Hage, C., Willman, C. L., Favara, B. E. & Isaacson, P. G. Langerhans' Cell Histiocytosis (Histiocytosis X): immunophenotype and growth fraction. Hum. Path. 24, 840-845 (1993).
26. Willman, C. L. et al. Langerhans'-Cell Histiocytosis (Histiocytosis X)-A clonal proliferative disease. N. Eng. J. Med. 331, 154-160 (1994).
27. Yu, R. C., Chu, C. E., Buluwela, L. & Chu, A. C. Langerhans cell histiocytosis: a clonal proliferation of langerhans cells. Lancet 343, 767-768 (1994).
28. Weiss, L. M., Wood, G. S. & Trela, M. Clonal T cell populations in lymphomatoid papulosis: evidnce of a lymphoproliferative origin for clinically benign disease. N. Eng. J. Med. 315, 475-479 (1986).
29. Posnett, D. N., Sinha, R., Kabak, S. & Russo, C. Clonal populations of T cells in normal elderly humans: the T cell equivalent to 'benign monoclonal gammopathy?' J. Exp. Med. 179, 609-618 (1994).
30. Dacic, S., Trusky, C., Bakker, A., Finkelstein, S. D. & Yousem, S. A. Genotypic analysis of pulmonary Langerhans cell histiocytosis. Hum. Pathol. 34, 1345-1349 (2003).
31. Murakami, I., Gogusev, J., Fournet, J. C., Glorion, C. & Jaubert, F. Detection of molecular cytogenetic aberrations in Langerhans cell histiocytosis of bone. Hum. Pathol. 33, 555-560 (2002).
32. Weintraub, M., Bhatia, K. G., Chandra, R. S., Magrath, I. T. & Ladisch, S. p53 expression in Langerhans cell histiocytosis. J. Pediatr. Hematol. Oncol. 20, 12-17 (1998).
33. Schouten, B. et al. Expression of cell cycle-related gene products in Langerhans cell histiocytosis. J. Pediatr. Hematol. Oncol. 24, 727-732 (2002).
34. Kannourakis, G. & Abbas, A. The role of cytokines in the pathogenesis of Langerhans Cell Histiocytosis. Br. J. Cancer 70, S37-S40 (1994).
35. de Graaf, J. H., Tamminga, R. Y. J., Kamps, W. A. & Timens, W. Langertians cell histiocytosis: expression of leukocyte cellular adhesion molecules suggests abnormal homing and differentiation. Am. J. Path. 144, 66-472 (1994).
36. Egeler, M., Favara, B., van Meurs, M., Laman, J. D. & Claassen, E. Differential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cutokines relevant to disease and treatment. Blood 94, 4195-4201 (1999).
37. Annels, N. E. et al. Aberrant chemokine receptor expression and chemokine production by langerhans cells underlies the pathogenesis of langerhans cell histiocytosis. J. Exp. Med. 197, 1385-1390 (2003).
38. Egeler, R. M., Favara, B. E., Laman, J. D. & Claassen, E. Abundant expression of CD40 and CD40-ligand (CD154) in paediatric Langerhans cell histiocytosis lesions. Eur. J. Can. 36, 2105-2110 (2000).
39. Caux, C., Dezutter-Dambuyant, C., Schmitt, D. & Banchereau, J. GM-CSF and TNFα cooperate in the generation of dendritic Langerhans cells. Nature 360, 258-260 (1992).
40. Medzhitov, R. & Janeway, C. A. Innate immunity: impact on the adaptive immune response. Curr. Op. Immunol. 9, 4-10 (1997).
41. Raquette, R. L. et al. Interferon-α and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells. J. Leuk. Biol. 64, 358-367 (1998).
42. + macrophage precursors commit sequentially to osteoclasts, dendritic cells and microglia. BMC Immunol. 3, 15-25 (2002).
43. da Costa, C. E. et al. Presence of osteoclast-like multinucleated giant cells in the bone and nonostotic lesions of Langerhans cell histiocytosis. J. Exp. Med. 201, 687-693 (2005).
44. Cremer, I. et al. Long-lived immature dendritic cells mediated by TRANCE-RANK interaction. Blood 100, 3646-3655 (2002).
45. Gunn, M. D. et al. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naïve T lymphocytes. Proc. Natl Acad. Sci. USA 95, 258-263 (1998).
46. Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245-252 (1998).
47. Geissmann, F. et al. Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 97, 1241-1248 (2001).
48. Pritchard, J. et al. The proceedings of the Nikolas Symposia on the histiocytoses 1989-1993. Br. J. Cancer 70, 31-373 (1994).
49. Laman, J. D., Leenen, P. J., Annels, N. E., Hogendoorn, P. C. & Egeler, R. M. Langerhans-cell histiocytosis 'insight into DC biology'. Trends Immunol. 24, 190-196 (2003).
50. Broadbent, V. et al. Spontaneous remission of multisystem histiocytosis X. Lancet 1, 253-254 (1984).